IS4848A - Lyfjafræðilega gagnleg efnasambönd - Google Patents

Lyfjafræðilega gagnleg efnasambönd

Info

Publication number
IS4848A
IS4848A IS4848A IS4848A IS4848A IS 4848 A IS4848 A IS 4848A IS 4848 A IS4848 A IS 4848A IS 4848 A IS4848 A IS 4848A IS 4848 A IS4848 A IS 4848A
Authority
IS
Iceland
Prior art keywords
pharmaceutically useful
useful compounds
compounds
pharmaceutically
useful
Prior art date
Application number
IS4848A
Other languages
English (en)
Icelandic (is)
Inventor
Bantick John
Bonnert Roger
Cage Peter
Donald David
Furber Mark
Hirst Simon
Perry Matthew
Phillips Eifron
Original Assignee
Astra Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605803.7A external-priority patent/GB9605803D0/en
Priority claimed from GBGB9610474.0A external-priority patent/GB9610474D0/en
Priority claimed from GBGB9610894.9A external-priority patent/GB9610894D0/en
Priority claimed from GBGB9700862.7A external-priority patent/GB9700862D0/en
Application filed by Astra Pharmaceuticals Ltd. filed Critical Astra Pharmaceuticals Ltd.
Publication of IS4848A publication Critical patent/IS4848A/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS4848A 1996-03-20 1998-09-16 Lyfjafræðilega gagnleg efnasambönd IS4848A (is)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9605803.7A GB9605803D0 (en) 1996-03-20 1996-03-20 Pharmaceutically-active compound
GBGB9610474.0A GB9610474D0 (en) 1996-05-18 1996-05-18 Pharmaceutically active compounds
GBGB9610894.9A GB9610894D0 (en) 1996-05-24 1996-05-24 Pharmaceutically useful compounds
GBGB9700862.7A GB9700862D0 (en) 1997-01-16 1997-01-16 Pharmaceutically useful compounds
PCT/SE1997/000471 WO1997034893A1 (en) 1996-03-20 1997-03-20 Pharmaceutically useful compounds

Publications (1)

Publication Number Publication Date
IS4848A true IS4848A (is) 1998-09-16

Family

ID=27451427

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4848A IS4848A (is) 1996-03-20 1998-09-16 Lyfjafræðilega gagnleg efnasambönd

Country Status (19)

Country Link
EP (1) EP0888347A1 (no)
JP (1) JP2000506884A (no)
KR (1) KR20000064716A (no)
CN (1) CN1218472A (no)
AR (1) AR006520A1 (no)
AU (1) AU712141B2 (no)
BR (1) BR9708103A (no)
CA (1) CA2247814A1 (no)
CZ (1) CZ297798A3 (no)
EE (1) EE9800298A (no)
ID (1) ID16283A (no)
IL (1) IL126271A0 (no)
IS (1) IS4848A (no)
NO (1) NO984290L (no)
NZ (1) NZ331614A (no)
PL (1) PL328921A1 (no)
SK (1) SK118798A3 (no)
TR (1) TR199801861T2 (no)
WO (1) WO1997034893A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110749A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Substituierte Aminodicarbonsäurederivate
JP2003002863A (ja) * 2001-06-25 2003-01-08 Nippon Soda Co Ltd 安息香酸類の製造方法および新規化合物
SE0102404D0 (sv) * 2001-07-04 2001-07-04 Active Biotech Ab Novel immunomodulating compounds
US6642249B2 (en) 2001-07-04 2003-11-04 Active Biotech Ab Immunomodulating compounds
DE10229762A1 (de) * 2002-07-03 2004-01-22 Aventis Pharma Deutschland Gmbh Pyrazoloisoquinolinenderivaten zur Inhibierung von NFkappaB-induzierende Kinase
EP1813616B1 (en) * 2002-11-22 2013-03-27 Active Biotech AB Pyrazoloquinolines with immunomodulating activity
DE60326639D1 (de) * 2002-12-16 2009-04-23 Active Biotech Ab Tetrazyklische immunmodulierende verbindungen
US7276505B2 (en) 2003-03-14 2007-10-02 Medigene Limited Immunomodulating heterocyclic compounds
GB0325644D0 (en) 2003-11-04 2003-12-10 Avidex Ltd Immuno ihibitory pyrazolone compounds
BRPI0417543A (pt) 2003-12-12 2007-03-27 Wyeth Corp quinolinas úteis no tratamento de doença cardiovascular
FR2870239B1 (fr) * 2004-05-11 2006-06-16 Sanofi Synthelabo Derives de carbamate de 2h- ou 3h-benzo[e]indazol-1-yle, leur preparation et leur application en therapeutique.
GB0411770D0 (en) * 2004-05-26 2004-06-30 Avidex Ltd Immuno inhibitory heterocyclic compouds
WO2006016093A1 (en) * 2004-08-09 2006-02-16 Avidex Limited Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors
CN101541757A (zh) 2006-10-31 2009-09-23 辉瑞产品公司 作为盐皮质激素受体拮抗剂的吡唑啉类化合物
CN102372710A (zh) * 2010-08-18 2012-03-14 山东轩竹医药科技有限公司 作为盐皮质激素受体拮抗剂的并环类化合物
JPWO2012108511A1 (ja) 2011-02-09 2014-07-03 日産化学工業株式会社 ピラゾール誘導体および有害生物防除剤
EP3846904B1 (en) * 2018-09-07 2023-05-31 Merck Patent GmbH 5-morpholin-4-yl-pyrazolo[4,3-b]pyridine derivatives
US11691971B2 (en) 2020-06-19 2023-07-04 Incyte Corporation Naphthyridinone compounds as JAK2 V617F inhibitors
US11753413B2 (en) 2020-06-19 2023-09-12 Incyte Corporation Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors
JP2023533724A (ja) 2020-07-02 2023-08-04 インサイト・コーポレイション Jak2 v617f阻害剤としての三環式尿素化合物
US11767323B2 (en) 2020-07-02 2023-09-26 Incyte Corporation Tricyclic pyridone compounds as JAK2 V617F inhibitors
WO2022046989A1 (en) 2020-08-27 2022-03-03 Incyte Corporation Tricyclic urea compounds as jak2 v617f inhibitors
WO2022140231A1 (en) 2020-12-21 2022-06-30 Incyte Corporation Deazaguaine compounds as jak2 v617f inhibitors
US11958861B2 (en) 2021-02-25 2024-04-16 Incyte Corporation Spirocyclic lactams as JAK2 V617F inhibitors
WO2023178285A1 (en) 2022-03-17 2023-09-21 Incyte Corporation Tricyclic urea compounds as jak2 v617f inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524146A (en) * 1982-12-08 1985-06-18 Ciba-Geigy Corporation Certain -2-heterocycle substituted pyrazoloquinolines
JPS61112075A (ja) * 1984-11-05 1986-05-30 Shionogi & Co Ltd チエニルピラゾロキノリン誘導体
SE8903564D0 (sv) * 1989-10-26 1989-10-26 Pharmacia Ab New use condensed quinoline compound
JPH05194515A (ja) * 1991-07-31 1993-08-03 Kyowa Hakko Kogyo Co Ltd 縮合ナフチリジン誘導体

Also Published As

Publication number Publication date
NZ331614A (en) 2000-07-28
BR9708103A (pt) 1999-07-27
AU2186797A (en) 1997-10-10
IL126271A0 (en) 1999-05-09
JP2000506884A (ja) 2000-06-06
AU712141B2 (en) 1999-10-28
CA2247814A1 (en) 1997-09-25
EE9800298A (et) 1999-02-15
NO984290D0 (no) 1998-09-16
AR006520A1 (es) 1999-09-08
EP0888347A1 (en) 1999-01-07
SK118798A3 (en) 1999-03-12
ID16283A (id) 1997-09-18
WO1997034893A1 (en) 1997-09-25
CZ297798A3 (cs) 1999-03-17
CN1218472A (zh) 1999-06-02
NO984290L (no) 1998-10-27
TR199801861T2 (xx) 1998-12-21
PL328921A1 (en) 1999-03-01
KR20000064716A (ko) 2000-11-06

Similar Documents

Publication Publication Date Title
ID19609A (id) Senyawa-senyawa heterosiklik
ID19403A (id) Senyawa-senyawa heterosiklik
ID16152A (id) Senyawa-senyawa triaril
ID15904A (id) Senyawa-senyawa tiofenopirimidina
ID19430A (id) Senyawa senyawa heterosiklik
BR9709230A (pt) Composto
IS4848A (is) Lyfjafræðilega gagnleg efnasambönd
ID19476A (id) Senyawa piridilpirol
BR9707051A (pt) Composto
DE69716924D1 (de) Phosphonat-nukleotid-verbindungen
ID18685A (id) Senyawa trisiklik tersubstitusi
ID19075A (id) Perangkap tempat kaustik untuk asetaldehida
EE9800430A (et) Uued ühendid
BR9705635A (pt) Compostos
BR9711205A (pt) Composto
NO983090D0 (no) Terapeutiske forbindelser
DK0923594T3 (da) Bromotiacumicinforbindelser
FI962420A0 (fi) Foerstaerkare med laogbrus
DE69709659D1 (de) Halopropargyl-einschlussverbindungen
IS4932A (is) Ný efnasambönd
SE9603300D0 (sv) Compounds
ID17103A (id) Senyawa-senyawa sulfonamida
SE9600275D0 (sv) Compounds
SE9603464D0 (sv) New compounds
SE9603505D0 (sv) New compounds